7SN2

Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab

7SN2 の概要

• エントリーDOI: 10.2210/pdb7sn2/pdb
• EMDBエントリー: 25209
• 分子名称: Spike glycoprotein, neutralizing antibody C1C-A3 Fab heavy chain, neutralizing antibody C1C-A3 Fab light chain, ... (5 entities in total)
• 機能のキーワード: covid-19, sars-cov-2, neutralizing antibody, neutralization escape, immune system
• 由来する生物種: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2); 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 196014.67

構造登録者

Pan, J.,Abraham, J.,Yang, P.,Shankar, S. (登録日: 2021-10-27, 公開日: 2021-12-08, 最終更新日: 2022-02-02)

• 主引用文献: Nabel, K.G.,Clark, S.A.,Shankar, S.,Pan, J.,Clark, L.E.,Yang, P.,Coscia, A.,McKay, L.G.A.,Varnum, H.H.,Brusic, V.,Tolan, N.V.,Zhou, G.,Desjardins, M.,Turbett, S.E.,Kanjilal, S.,Sherman, A.C.,Dighe, A.,LaRocque, R.C.,Ryan, E.T.,Tylek, C.,Cohen-Solal, J.F.,Darcy, A.T.,Tavella, D.,Clabbers, A.,Fan, Y.,Griffiths, A.,Correia, I.R.,Seagal, J.,Baden, L.R.,Charles, R.C.,Abraham, J.; Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.; Science, 375:eabl6251-eabl6251, 2022; PubMed: 34855508; DOI: 10.1126/science.abl6251

実験手法

ELECTRON MICROSCOPY (4.3 Å)